Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prins

Showing results (511-520 of 774) with videos related to

Pageof 78
Sort By:
Mucosal Immunology|August 30, 2019
TOLLIP deficiency is associated with increased resistance to Legionella pneumophila pneumoniaJaveed A Shah, Robyn Emery, Brian Lee, et al.
AIDS (London, England)|December 20, 2003
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimenSanjay U C Sankatsing, Gerrit J Weverling, Monika Peeters, et al.
AIDS (London, England)|February 19, 2005
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort studyFerdinand Wnm Wit, Daniel H Blanckenberg, Kees Brinkman, et al.
Therapeutic Drug Monitoring|July 17, 2004
Race is not associated with nevirapine pharmacokineticsMonique M R de Maat, Jeannine F J B Nellen, Alwin D R Huitema, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 25, 2005
[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia]J A Schouten, J M Prins, M Bonten, et al.
AIDS (London, England)|April 9, 2009
Clinical experience with the combined use of lopinavir/ritonavir and rifampicinRafaëlla Fa L'homme, Hanneke M J Nijland, Luuk Gras, et al.
AIDS (London, England)|October 21, 2003
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patientsMarchina E van der Ende, Jan M Prins, Kees Brinkman, et al.
BMC Infectious Diseases|April 19, 2015
A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: the AB-checklistFrederike V van Daalen, Jan M Prins, Brent C Opmeer, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 15, 2006
[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections]S E Geerlings, P J van den Broek, E P van Haarst, et al.
AIDS (London, England)|January 3, 2012
Low prevalence of asymptomatic sexually transmitted infections in HIV-infected heterosexuals visiting an HIV clinic in the NetherlandsMarlies Heiligenberg, Maarten F Schim van der Loeff, Henry J C de Vries, et al.
Pageof 78

Showing results (511-520 of 774) with videos related to

Sort By:
Pageof 78
Mucosal Immunology|August 30, 2019
TOLLIP deficiency is associated with increased resistance to Legionella pneumophila pneumoniaJaveed A Shah, Robyn Emery, Brian Lee, et al.
AIDS (London, England)|December 20, 2003
TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimenSanjay U C Sankatsing, Gerrit J Weverling, Monika Peeters, et al.
AIDS (London, England)|February 19, 2005
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort studyFerdinand Wnm Wit, Daniel H Blanckenberg, Kees Brinkman, et al.
Therapeutic Drug Monitoring|July 17, 2004
Race is not associated with nevirapine pharmacokineticsMonique M R de Maat, Jeannine F J B Nellen, Alwin D R Huitema, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 25, 2005
[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia]J A Schouten, J M Prins, M Bonten, et al.
AIDS (London, England)|April 9, 2009
Clinical experience with the combined use of lopinavir/ritonavir and rifampicinRafaëlla Fa L'homme, Hanneke M J Nijland, Luuk Gras, et al.
AIDS (London, England)|October 21, 2003
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patientsMarchina E van der Ende, Jan M Prins, Kees Brinkman, et al.
BMC Infectious Diseases|April 19, 2015
A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: the AB-checklistFrederike V van Daalen, Jan M Prins, Brent C Opmeer, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 15, 2006
[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections]S E Geerlings, P J van den Broek, E P van Haarst, et al.
AIDS (London, England)|January 3, 2012
Low prevalence of asymptomatic sexually transmitted infections in HIV-infected heterosexuals visiting an HIV clinic in the NetherlandsMarlies Heiligenberg, Maarten F Schim van der Loeff, Henry J C de Vries, et al.
Pageof 78